Treatment of Behcet’ s disease

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

DAVATCHI FEREYDOUN; MOGHIMI NASRIN; MOUSAVI MOHAMMAD; FATEMI ALIMOHAMMAD

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Chronic Diseases Journal Year:2013 | Volume:1 | Issue:1 Page(s): 42-54

Download Full-Text

View:

383

Download:

179

Cites:

Information Journal Paper

Title

Treatment of Behcet’ s disease

Author(s)

DAVATCHI FEREYDOUN | MOGHIMI NASRIN | MOUSAVI MOHAMMAD | FATEMI ALIMOHAMMAD | Issue Writer Certificate

Keywords

Behcet’s Disease

Treatment

Manifestation

Diagnosis

Abstract

Behcet’ s disease is a systemic disease classified among vasculitides. Major Manifestations are mucous membrane lesions (oral aphthosis and genital aphthosis), skin Manifestations (pseudofolliculitis, erythema nodosum), ocular Manifestations (uveitis, retinal vasculitis), joint Manifestations, vascular lesions (small to large vessel thrombosis, aneurysm), gastrointestinal Manifestations, orchiepididymitis, and some rare Manifestations like cardiac, pulmonary, and renal impairment. Diagnosis is mainly clinical. The International Diagnosis Criteria for Behcet’ s Disease may be of help. The gold standard of Treatment for mucocutaneous lesions is colchicine. In refractory cases, levamisole, thalidomide, and dapsone may be of help. For major organ involvement like the eyes and the brain, immunosuppressive drugs and prednisolone are the gold standard. In refractory cases, biological agents are the last resort. For gastrointestinal Manifestations, sulfasalazine and prednisolone are the first-line Treatment. For vascular involvement, the first line Treatment was anticoagulation, but recently it was shown that immunosuppressive drugs and prednisolone were confirmed to be the best. In all refractory cases and for all different organs, the last resort is biological agents.

Cites

No record.

References

No record.

Cite

APA: Copy

DAVATCHI, FEREYDOUN, MOGHIMI, NASRIN, MOUSAVI, MOHAMMAD, & FATEMI, ALIMOHAMMAD. (2013). Treatment of Behcet’ s disease. CHRONIC DISEASES JOURNAL, 1(1), 42-54. SID. https://sid.ir/paper/303632/en

Vancouver: Copy

DAVATCHI FEREYDOUN, MOGHIMI NASRIN, MOUSAVI MOHAMMAD, FATEMI ALIMOHAMMAD. Treatment of Behcet’ s disease. CHRONIC DISEASES JOURNAL[Internet]. 2013;1(1):42-54. Available from: https://sid.ir/paper/303632/en

IEEE: Copy

FEREYDOUN DAVATCHI, NASRIN MOGHIMI, MOHAMMAD MOUSAVI, and ALIMOHAMMAD FATEMI, “Treatment of Behcet’ s disease,” CHRONIC DISEASES JOURNAL, vol. 1, no. 1, pp. 42–54, 2013, [Online]. Available: https://sid.ir/paper/303632/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops